MX2021005963A - Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar. - Google Patents

Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar.

Info

Publication number
MX2021005963A
MX2021005963A MX2021005963A MX2021005963A MX2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A
Authority
MX
Mexico
Prior art keywords
characterizing
rna
proteins
detection
methylated dna
Prior art date
Application number
MX2021005963A
Other languages
English (en)
Inventor
Hatim Allawi
Graham P Lidgard
Maria Giakoumopoulos
David A Ahlquist
William R Taylor
Douglas Mahoney
Original Assignee
Exact Sciences Dev Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exact Sciences Dev Co Llc filed Critical Exact Sciences Dev Co Llc
Publication of MX2021005963A publication Critical patent/MX2021005963A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

En el presente documento se proporciona tecnología relacionada con la detección de neoplasias y, en particular, pero no exclusivamente, con métodos, composiciones y usos relacionados para detectar neoplasias tales como cáncer de pulmón.
MX2021005963A 2018-11-27 2019-11-26 Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar. MX2021005963A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862771965P 2018-11-27 2018-11-27
PCT/US2019/063401 WO2020112869A1 (en) 2018-11-27 2019-11-26 Characterizing methylated dna, rna, and proteins in the detection of lung neoplasia

Publications (1)

Publication Number Publication Date
MX2021005963A true MX2021005963A (es) 2021-08-24

Family

ID=70853661

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005963A MX2021005963A (es) 2018-11-27 2019-11-26 Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar.

Country Status (10)

Country Link
US (1) US20220136058A1 (es)
EP (1) EP3886878A4 (es)
JP (1) JP2022513658A (es)
KR (1) KR20210099044A (es)
CN (1) CN113423410A (es)
AU (1) AU2019389008A1 (es)
BR (1) BR112021009795A2 (es)
CA (1) CA3119329A1 (es)
MX (1) MX2021005963A (es)
WO (1) WO2020112869A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3126529B1 (en) 2014-03-31 2020-05-27 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
CN108350485A (zh) 2015-10-30 2018-07-31 精密科学发展有限责任公司 血浆dna的多重扩增检测测定以及分离和检测
US10385406B2 (en) 2016-05-05 2019-08-20 Exact Sciences Development Company, Llc Detection of lung neoplasia by analysis of methylated DNA
AU2018211956A1 (en) 2017-01-27 2019-07-25 Exact Sciences Corporation Detection of colon neoplasia by analysis of methylated DNA
AU2020336115A1 (en) * 2019-08-27 2022-04-14 Exact Sciences Corporation Characterizing methylated DNA, RNA, and proteins in subjects suspected of having lung neoplasia
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
US11530453B2 (en) 2020-06-30 2022-12-20 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
EP3945135A1 (en) * 2020-07-27 2022-02-02 Les Laboratoires Servier Biomarkers for diagnosing and monitoring lung cancer
CN115725734B (zh) * 2022-08-10 2023-10-13 人和未来生物科技（长沙）有限公司 Znf781基因在制备宫颈癌诊断试剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074924A1 (en) * 2008-12-23 2010-07-01 University Of Utah Research Foundation Identification and regulation of a novel dna demethylase system
WO2013070950A1 (en) * 2011-11-08 2013-05-16 University Of Southern California Identification of a dna methylation marker for blood-based detection of ovarian cancer
US9546403B1 (en) * 2011-12-14 2017-01-17 University Of Utah Research Foundation Substrate for methylated DNA testing
EP3889611A1 (en) * 2014-12-12 2021-10-06 Exact Sciences Development Company, LLC Compositions and methods for performing methylation detection assays
US10385406B2 (en) * 2016-05-05 2019-08-20 Exact Sciences Development Company, Llc Detection of lung neoplasia by analysis of methylated DNA
KR20190026769A (ko) * 2016-06-21 2019-03-13 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
CN109642228B (zh) * 2016-07-19 2022-09-13 精密科学发展有限责任公司 甲基化对照dna

Also Published As

Publication number Publication date
EP3886878A4 (en) 2022-11-02
EP3886878A1 (en) 2021-10-06
JP2022513658A (ja) 2022-02-09
CN113423410A (zh) 2021-09-21
BR112021009795A2 (pt) 2021-08-17
WO2020112869A1 (en) 2020-06-04
US20220136058A1 (en) 2022-05-05
KR20210099044A (ko) 2021-08-11
AU2019389008A1 (en) 2021-06-03
CA3119329A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
MX2021005963A (es) Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar.
AU2017260630A1 (en) Detection of lung neoplasia by analysis of methylated DNA
AU2020336115A8 (en) Characterizing methylated DNA, RNA, and proteins in subjects suspected of having lung neoplasia
PH12018501159A1 (en) Composition and methods for immunooncology
EP4234722A3 (en) Detecting colorectal neoplasm
SG11201805531UA (en) Molecular detection/diagnosis reagent for tumor
EA201201000A1 (ru) Способы лечения колоректального рака
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
EP4303314A3 (en) Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
MX2017012352A (es) Construccion dirigida a complejos de peptido de alfa-fetoproteina/complejo principal de histocompatibilidad (afp/cph) y usos de los mismos.
AU2015205612A8 (en) Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines
GB2526736A (en) Methods, compositions, and kits for nucleic acid analysis
BR112015009752A2 (pt) conjugados de anticorpo/fármaco e métodos de uso
GB2539350A (en) Amyloid targeting agents and methods of using the same
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
MX2016000997A (es) Metodos y composiciones para detectar contaminacion bacteriana.
PH12019502171A1 (en) Composition and methods for immunooncology
AR093446A1 (es) Anticuerpos de antihemaglutinina y metodos de uso
WO2018081592A3 (en) Compositions and methods for the production of compounds
EA201391577A1 (ru) Композиция, включающая афлиберцепт, фолиновую кислоту, 5-фторурацил (5-fu) и ириноцетан (folfiri)
WO2018136919A3 (en) Methods relating to lung cancer
EA201390694A1 (ru) Способы лечения рака
CY1122156T1 (el) Αντισωματα κατα του σχετιζομενου με τον νεφρο αντιγονου 1 και αντιγονοδεσμευτικα θραυσματα αυτων
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
WO2012154983A3 (en) Systems and methods for anti-pax8 antibodies